Skip to content

FP7H2020HORIZON

Centre de Lutte Contre le Cancer Leon Berard

Country
FRFrance
Defence projects
0
Projects, all programmes
18
As coordinator
3
EU contribution (CORDIS)
EUR 7,234,619
Active
2009 to 2024

Projects

18 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
UPLIFTUPright radiotherapy: Learning, Innovation, Fellowship and TrainingHORIZON2024ParticipantEUR 565,387
SALVOVARA EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVESHORIZON2023ParticipantEUR 171,875
IDEA4RCIntelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare CancersHORIZON2022ParticipantEUR 336,388
STRONG-AYATHE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCERHORIZON2022ParticipantEUR 629,923
PROTECT-trialProton versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyH20202021ParticipantEUR 5,075
ERICAEuropean Rare dIsease research Coordination and support ActionH20202021ParticipantEUR 17,500
QUALITOPMonitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient managementH20202020ParticipantEUR 71,625
Instand-NGS4PIntegrated and standardized NGS workflows for Personalised therapyH20202020ParticipantEUR 261,257
SELNETSarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary networkH20202019ParticipantEUR 486,000
EJP RDEuropean Joint Programme on Rare DiseasesH20202019ParticipantEUR 14,033
TUMADORDevelopment of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancersFP72013CoordinatorEUR 1,863,992
GANNET53A drug strategy targeting heat shock protein 90 to combat metastatic, p53 mutant ovarian cancer.FP72013ParticipantEUR 221,718
HERMIONE-2MANFirst in Man Novel Anticancer Therapeutic based on Dependence Receptors ConceptFP72013CoordinatorEUR 1,587,623
EECEURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing SarcomaFP72013ParticipantEUR 524,761
ENCCAEUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTSFP72011ParticipantEUR 130,152
NOTCH3DRInvestigating a novel role of Notch3 as a dependence receptor and its relevance in vivoFP72010CoordinatorEUR 166,146
COGSCollaborative Oncological Gene-environment StudyFP72009ParticipantEUR 136,884
DISMEVALDeveloping and validating disease management evaluation methods for European health care systemsFP72009ParticipantEUR 44,280

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.